datasets
Training and evaluation data, with the modality, task and licence stated up front. Listed live from the Hugging Face Hub.
glp1-telehealth-pricing-2026
GLP-1 Weight Loss Telehealth Pricing Index — United States, 2026
Publisher: Ozari Health | ozarihealth.comLicense: CC-BY-4.0Last updated: May 2026Rows: 120+ across 90+ providersHuggingFace: https://huggingface.co/datasets/Ozarihealth/glp1-telehealth-pricing-2026
About This Dataset
The US market for GLP-1 weight loss medications has expanded to include dozens of
telehealth platforms, each with different pricing structures, plan lengths, membership
fees, and pharmacy… See the full description on the dataset page: https://huggingface.co/datasets/Ozarihealth/glp1-telehealth-pricing-2026.compounded-glp1-evidence-audit
Compounded GLP-1 products: seven published sources coded for human evidence, comparator and independence
An editorially selected audit of seven published sources bearing on whether compounded GLP-1 products have the same human evidence as approved products. Each source is coded against five explicit gates covering the test article, human administration, comparator, equivalence and independence. Version 1.1.0 adds Talay 2024, a comparative cohort indexed outside PubMed.
Read the… See the full description on the dataset page: https://huggingface.co/datasets/lifescore/compounded-glp1-evidence-audit.glp1-side-effects-2026
GLP-1 Medication Side Effects Frequency Database — 2026
Publisher: Ozari Health | ozarihealth.com
License: CC-BY-4.0
Last updated: May 2026
Rows: 40 adverse events across 5 medications
HuggingFace: https://huggingface.co/datasets/Ozarihealth/glp1-side-effects-2026
About This Dataset
A structured database of adverse event frequency data for GLP-1 weight loss medications, sourced from published Phase 3 clinical trials and FDA prescribing information. Each row… See the full description on the dataset page: https://huggingface.co/datasets/Ozarihealth/glp1-side-effects-2026.glp1-clinical-trials-2026
GLP-1 Clinical Trials Index — 2026
Publisher: Ozari Health | ozarihealth.comLicense: CC-BY-4.0Last updated: May 2026Rows: 22 trialsHuggingFace: https://huggingface.co/datasets/Ozarihealth/glp1-clinical-trials-2026
About This Dataset
A structured index of every major published GLP-1 clinical trial as of May 2026. This dataset consolidates trial-level data from peer-reviewed publications into a single comparable format — covering semaglutide, tirzepatide, liraglutide, oral… See the full description on the dataset page: https://huggingface.co/datasets/Ozarihealth/glp1-clinical-trials-2026.telehealth-glp1-pricing
Telehealth GLP-1 Pricing Comparison — July 2026
A structured comparison of monthly out-of-pocket costs for GLP-1 weight loss medications (semaglutide, tirzepatide) across major US telehealth platforms and direct-pay manufacturer programs as of July 23, 2026 (Belle Health rows re-collected July 27, 2026 — see Changelog).
Dataset summary
This dataset captures publicly advertised pricing for GLP-1 medications across:
Compounded GLP-1 telehealth providers — Cora… See the full description on the dataset page: https://huggingface.co/datasets/cora-health/telehealth-glp1-pricing.glp1-telehealth-pricing-2026
GLP-1 Telehealth Pricing 2026
A public, openly-licensed dataset of advertised U.S. telehealth pricing for compounded
GLP-1 weight-loss medications (semaglutide and tirzepatide), compiled and published by
Nouri (joinnouri.com).
It exists because GLP-1 telehealth pricing is unusually hard to compare: providers
advertise different "from" prices for different commitment lengths, some require a
separate membership fee that is not shown in the headline price, and figures change… See the full description on the dataset page: https://huggingface.co/datasets/nouriadmin/glp1-telehealth-pricing-2026.cms-glp1-data
The GLP-1 Spending Explosion (2017-2025)
Everyone's heard about Ozempic, Wegovy, and Mounjaro by now. But how much is Medicare actually spending on these drugs, and how fast is it growing? That's what this dataset is about.
I pulled together state-by-state Medicare Part D spending data on GLP-1 medications going back to 2017, when Ozempic first got FDA approval. The dataset covers all 50 states and territories through 2023 at the state level, plus provisional 2024 and 2025 national… See the full description on the dataset page: https://huggingface.co/datasets/sbreitenbach/cms-glp1-data.GLP-1RAs_Validated_by_in_vivo
Dataset Card for Dataset Name
The GLP-1 RAs at each in vivo step of "AI-Driven Efficient De Novo design of GLP-1RAs with Extended Half-Life and Enhanced Efficacy".
Dataset Description
We designed 10,000 de novo GLP-1 receptor agonists (GLP-1RAs), 60 of these satisfied the stability, efficacy, and diversity criteria in the virtual functional screening. In vitro validation revealed a 52% success rate, and in vivo experiments demonstrated that two lead GLP-1RAs (D13 and… See the full description on the dataset page: https://huggingface.co/datasets/weitinging/GLP-1RAs_Validated_by_in_vivo.GLP1
